H-1B sponsorship profile: Juno Therapeutics, Inc. Across U.S. Department of Labor LCA disclosures, Juno Therapeutics, Inc filed 6 Labor Condition Applications covering 6 H-1B worker positions between fiscal year 2023 and fiscal year 2023. The employer’s DOL certification rate sits at 83.3% (5 certified of 6 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Juno Therapeutics, Inc’s H-1B petitions range from $97,850 at the low end to $159,650 at the high end, with a petition-weighted average of $113,392. That range reflects the mix of occupations the company sponsors, led by Senior Specialist, Product Management (2 petitions at $97,850 avg), followed by Quality Control Microbiology Supervisor and Principal Scientist. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Juno Therapeutics, Inc is headquartered in Seattle, WA under NAICS code 541714, and places H-1B workers across 1 state, most heavily in WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Juno Therapeutics, Inc ranks. By H-1B petition volume, Juno Therapeutics, Inc is #23,486 of 119,880 employers nationally and #437 of 2,468 employers headquartered in WA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.